BGM Group’s revenue from AI soars, profits jump 78%, yet shares remain undervalued. Read why I think BGM stock is a Buy right now and has some upside.

Get going with our next company presenter at the BofA Healthcare Conference here in London. Pleased to be introducing Teva Pharmaceuticals and CEO, Richard Francis. My name is Jason Gerberry. I'm one ...